000 | 01947 a2200529 4500 | ||
---|---|---|---|
005 | 20250517040115.0 | ||
264 | 0 | _c20160520 | |
008 | 201605s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2015.06.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoucle, Sebastien | |
245 | 0 | 0 |
_aDesign, synthesis and evaluation of novel anti-HCV molecules that deliver intracellularly three highly potent NS5A inhibitors. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cSep 2015 |
||
300 |
_a3711-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 | _aCarbamates |
650 | 0 | 4 |
_aCell Line _xdrug effects |
650 | 0 | 4 | _aChemistry Techniques, Synthetic |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 |
_aHepacivirus _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPyrrolidines |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aValine _xanalogs & derivatives |
650 | 0 | 4 |
_aVero Cells _xdrug effects |
650 | 0 | 4 |
_aViral Nonstructural Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
700 | 1 | _aTao, Sijia | |
700 | 1 | _aAmblard, Franck | |
700 | 1 | _aStanton, Richard A | |
700 | 1 | _aNettles, James H | |
700 | 1 | _aLi, Chengwei | |
700 | 1 | _aMcBrayer, Tamara R | |
700 | 1 | _aWhitaker, Tony | |
700 | 1 | _aCoats, Steven J | |
700 | 1 | _aSchinazi, Raymond F | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 25 _gno. 17 _gp. 3711-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2015.06.031 _zAvailable from publisher's website |
999 |
_c25006254 _d25006254 |